[go: up one dir, main page]

UA42693C2 - The medicine for treating the infection by lentivirus, the preparation for human treatment which is infected by lentivirus. - Google Patents

The medicine for treating the infection by lentivirus, the preparation for human treatment which is infected by lentivirus.

Info

Publication number
UA42693C2
UA42693C2 UA94129236A UA94129236A UA42693C2 UA 42693 C2 UA42693 C2 UA 42693C2 UA 94129236 A UA94129236 A UA 94129236A UA 94129236 A UA94129236 A UA 94129236A UA 42693 C2 UA42693 C2 UA 42693C2
Authority
UA
Ukraine
Prior art keywords
lentivirus
infection
medicine
treating
infected
Prior art date
Application number
UA94129236A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Нікола МОНДЖЕЛЛІ
Никола Монджелли
Джованні БІАСОЛІ
Джованни Биасоли
Марія ГРАНДІ
Мария Гранди
Маріна ЧІОМЕІ
Марина Чиомеи
Марія Крістна ДЖЕРОНІ
Мария Кристна ДЖЕРОНИ
Original Assignee
Фармація Енд Апджон С.П.А.
Фармация Энд Апджон С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармація Енд Апджон С.П.А., Фармация Энд Апджон С.П.А. filed Critical Фармація Енд Апджон С.П.А.
Publication of UA42693C2 publication Critical patent/UA42693C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Use of compound according to formula (I): where each of m and n are identical and represented by integer from 1 to 3, all R group are identical and represented by naphthyl, substituted by 1-3 sulphogroups, or its pharmaceutical acceptable salt as the medicine for treating the infection by lentivirus, which is the virus of the immunodeficiency of human.
UA94129236A 1993-04-16 1994-03-29 The medicine for treating the infection by lentivirus, the preparation for human treatment which is infected by lentivirus. UA42693C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939307948A GB9307948D0 (en) 1993-04-16 1993-04-16 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
PCT/EP1994/000984 WO1994023718A1 (en) 1993-04-16 1994-03-29 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease

Publications (1)

Publication Number Publication Date
UA42693C2 true UA42693C2 (en) 2001-11-15

Family

ID=10733998

Family Applications (1)

Application Number Title Priority Date Filing Date
UA94129236A UA42693C2 (en) 1993-04-16 1994-03-29 The medicine for treating the infection by lentivirus, the preparation for human treatment which is infected by lentivirus.

Country Status (15)

Country Link
EP (1) EP0646004A1 (en)
JP (1) JPH07508044A (en)
KR (1) KR950701812A (en)
AU (1) AU670194B2 (en)
CA (1) CA2137148A1 (en)
CZ (1) CZ282988B6 (en)
GB (1) GB9307948D0 (en)
HU (1) HU216834B (en)
IL (1) IL109235A (en)
NO (1) NO307126B1 (en)
PL (1) PL306798A1 (en)
RU (1) RU2142798C1 (en)
TW (1) TW308593B (en)
UA (1) UA42693C2 (en)
WO (1) WO1994023718A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504065D0 (en) * 1995-03-01 1995-04-19 Pharmacia Spa Poly-pyrrolecarboxamidonaphthalenic acid derivatives
GB9602721D0 (en) * 1996-02-09 1996-04-10 Pharmacia Spa Biologically active ureido derivatives useful in the treatment of multiple sclerosis
GB2310207A (en) * 1996-02-15 1997-08-20 Pharmacia Spa Antiviral ureido derivatives of substituted heterocyclic compounds
GB9713733D0 (en) * 1997-06-27 1997-09-03 Pharmacia & Upjohn Spa Poly-branched polycarboxamido compounds
EP3381897A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9000644D0 (en) * 1990-01-11 1990-03-14 Erba Carlo Spa New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
CA2103665C (en) * 1991-02-06 2003-04-15 J. William Lown Oligopeptide antiretroviral agents
IT1247878B (en) * 1991-02-15 1995-01-05 Menarini Farma Ind POLY-4-AMINOPYRROL-2-CARBOXYXID DERIVATIVES, PREPARATION PROCESSES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Also Published As

Publication number Publication date
PL306798A1 (en) 1995-04-18
HU216834B (en) 1999-09-28
NO307126B1 (en) 2000-02-14
AU670194B2 (en) 1996-07-04
HUT71838A (en) 1996-02-28
CA2137148A1 (en) 1994-10-27
NO944809L (en) 1994-12-12
CZ282988B6 (en) 1997-12-17
KR950701812A (en) 1995-05-17
JPH07508044A (en) 1995-09-07
NO944809D0 (en) 1994-12-12
RU2142798C1 (en) 1999-12-20
TW308593B (en) 1997-06-21
HU9500120D0 (en) 1995-03-28
WO1994023718A1 (en) 1994-10-27
EP0646004A1 (en) 1995-04-05
CZ10795A3 (en) 1995-09-13
IL109235A (en) 1998-09-24
AU6537194A (en) 1994-11-08
GB9307948D0 (en) 1993-06-02
IL109235A0 (en) 1994-07-31
RU94046312A (en) 1996-10-20

Similar Documents

Publication Publication Date Title
FI945625A0 (en) Indolcarbazole imides and their use
GR3034279T3 (en) Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
DE69019533D1 (en) TREATMENT OF HIV INFECTIONS AND USEFUL LINKS THEREFOR.
WO1998056761A3 (en) Benzimidazole derivatives
MY117892A (en) Therapeutic compounds
RU94002475A (en) Pharmaceutical composition and its use for viral infection treatment
IL101203A0 (en) Cyclic urea derivatives,their preparation and pharmaceutical compositions containing them
ATE130514T1 (en) USE OF NITROGEN CONTAINING MACROCYCLES TO TREAT RETROVIRAL INFECTIONS.
RU94022743A (en) Amido and carbamido derivatives having antihypercholesteric activity, preparation thereof, and therapeutic use thereof
AU2452288A (en) Nucleoside derivatives useful in treating retroviral infections
GR3025488T3 (en) Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
NZ324380A (en) Therapeutic benzimidazole compounds and their use in treatment of virus infections
AU549890B2 (en) Para-substituted-3-phenoxy-1-alkoxycarbenyl-alkylamino- propanol-2 compounds
UA42693C2 (en) The medicine for treating the infection by lentivirus, the preparation for human treatment which is infected by lentivirus.
CA2100066A1 (en) Michellamines useful as antiviral agents, composition and method of treatment
IL102815A (en) Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus
RU2003347C1 (en) Remedy for treatment of proteus infection
TH16738A (en) "A bioactive uredo derivative useful in the treatment of lentivirus disease"
RU93050541A (en) COMPOUNDS ALLOCATED FROM FAMILY PLANTS AND THEIR DERIVATIVES, METHOD FOR PRODUCING THEM AND APPLICATION
RU95108985A (en) Pharmaceutical composition for prophylaxis of the secondary immunodeficient states and a method of their prophylaxis
WO1988008707A3 (en) Rubradirin derivatives for treatment of hiv infection
ATE198272T1 (en) ANTIVIRAL COMPOSITIONS CONTAINING A COMBINATION OF A DIMETHYLBENZYLALKYLAMMONIUM IODIDE AND AN AMIDOALKYLAMMONIUM IODIDE